Clinical Trial Update: Study of Two Formulations of GSK Biologicals' Varicella Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing two formulations of GlaxoSmithKline's varicella vaccine has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine (varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Varicella | Phase 2 | Status: COMPLETED | Results posted: 2017-06-28